Pacific Biosciences of California, Inc. (PACB): Price and Financial Metrics

Pacific Biosciences of California, Inc. (PACB): $1.85

0.13 (-6.57%)

POWR Rating

Component Grades








PACB Price/Volume Stats

Current price $1.85 52-week high $14.55
Prev. close $1.98 52-week low $1.25
Day low $1.84 Volume 4,273,300
Day high $2.03 Avg. volume 9,865,302
50-day MA $2.03 Dividend yield N/A
200-day MA $6.08 Market Cap 503.86M

PACB Stock Price Chart Interactive Chart >

Pacific Biosciences of California, Inc. (PACB) Company Bio

Pacific Biosciences of California, Inc. designs, develops, manufactures, and markets an integrated platform for genetic analysis. The company was formerly known as Nanofluidics, Inc. The company was founded in 2000 and is based in Menlo Park, California.

PACB Latest News Stream

Event/Time News Detail
Loading, please wait...

PACB Latest Social Stream

Loading social stream, please wait...

View Full PACB Social Stream

Latest PACB News From Around the Web

Below are the latest news stories about PACIFIC BIOSCIENCES OF CALIFORNIA INC that investors may wish to consider to help them evaluate PACB as an investment opportunity.

PacBio to Present at 42nd Annual J.P. Morgan Healthcare Conference

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 1:30 PM PT (4:30 PM ET) in San Francisco, California.

Yahoo | December 27, 2023

CVRx (CVRX) Moves 24.2% Higher: Will This Strength Last?

CVRx (CVRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Yahoo | December 27, 2023

Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now

PacBio's (PACB) product development activities raise optimism about the stock.

Yahoo | December 26, 2023

12 Most Promising Gene Editing Stocks According to Hedge Funds

In this piece, we will take a look at the 12 most promising gene editing stocks according to hedge funds. If you want to skip our take on how the gene editing industry sits right at the top of the global innovation food chain, then you can take a look at the 5 Most Promising […]

Yahoo | December 20, 2023

Investors in Pacific Biosciences of California (NASDAQ:PACB) have unfortunately lost 60% over the last three years

Pacific Biosciences of California, Inc. ( NASDAQ:PACB ) shareholders should be happy to see the share price up 29% in...

Yahoo | December 12, 2023

Read More 'PACB' Stories Here

PACB Price Returns

1-mo -13.75%
3-mo -51.19%
6-mo -80.40%
1-year -86.10%
3-year -93.40%
5-year -72.18%
YTD -81.14%
2023 19.93%
2022 -60.02%
2021 -21.13%
2020 404.67%
2019 -30.54%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!